Modifiable environmental factors predispose term infants to bronchiolitis but bronchiolitis itself predisposes to respiratory sequelae.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
03 2022
Historique:
revised: 18 11 2021
received: 25 03 2021
accepted: 26 11 2021
pubmed: 18 12 2021
medline: 19 4 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

Viral bronchiolitis is a common lower respiratory tract infection in infants. Environmental and genetic factors can favor respiratory tract infections. The aim of this study is to analyze risk factors for bronchiolitis and to investigate the predisposing factors for developing transient wheezing and asthma through a 6-year follow-up after hospitalization for bronchiolitis compared with a group of healthy controls that belonged to Piccolipiù cohort, who never had bronchiolitis. We enrolled 645 infants hospitalized with bronchiolitis. A structured questionnaire was used to obtain demographic and clinical data. At 6 years of age, 370 cases and 183 controls were investigated for the presence of asthma by the structured questionnaire, for prick test and for spirometry, and were classified to asthmatic, transient wheezing, and no wheezing/no asthma. Breastfeeding was an independent protective factor (odds ratio [OR]: 0.3, 95% confidence interval [95% CI]: 0.2-0.4, p < 0.001) and tobacco smoke was a risk factor for the development of bronchiolitis (OR: 2.1, 95% CI: 1.4-3.1, p < 0.001). Analyzing follow-up, bronchiolitis increased the risk of developing transient wheezing by 12.9 (95% CI: 6.3-26.1, p < 0.001) and of developing asthma by 4.6 (95% CI: 1.9-10.7, p < 0.001). A positive family history of atopy increased the risk of developing asthma by 3.1 (95% CI: 1.4-6.7, p = 0.005). Asthmatic patients had a lower % FEV1, a lower % flow-volume curve (FVC), and a lower FEV1/FVC value, and they had more frequently positive skin prick test. Bronchiolitis is influenced by environmental factors: tobacco smoke increases its risk and breastfeeding is a protective factor. At the end of 6 years of follow-up, bronchiolitis is a significant risk factor to have pre-school wheezing and asthma.

Identifiants

pubmed: 34918490
doi: 10.1002/ppul.25794
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

640-647

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374:62-72.
Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. 2006;368:312-322.
Midulla F, Scagnolari C, Bonci E, et al. Respiratory syncytial virus, human bocavirus and rhinovirus in infants. Arch Dis Child. 2010;95:35-41.
Pérez-Yarza EG, Moreno-Galdó A, Ramilo O, et al. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life. Pediatr Allergy Immunol. 2015;26:797-804.
Alvarez AE, Marson FA, Bertuzzo CS, Arns CW, Ribeiro JD. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. J Pediatr. 2013;89(6):531-543.
Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet. 2014;383:1581-1592.
Nenna R, Cutrera R, Frassanito A, et al. Modifiable risk factors associated with bronchiolitis. Ther Adv Respir Dis. 2017;11(10):393-401.
Bradley JP, Bacharier LB, Bonfiglio J. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005;115(1):e7-e14.
Carrol KN, Gebretsadik T, Griffin MR. Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics. 2007;119(6):1104-1112.
Grimwood K, Cohet C, Rich FJ, et al. Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect. 2008;136(10):1333-1341.
Schippa S, Frassanito A, Marazzato M, et al. Nasal microbiota in RSV bronchiolitis. Microorganisms. 2020;8(5):731.
Teo SM, Mok D, Pham K, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17:704-715.
Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65:1045-1052.
Koponen P, Helminen M, Paassilta M, Luukkaala T, Korppi M. Preschool asthma after bronchiolitis in infancy. Eur Respir J. 2012;39:76-80.
Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illness in early life predict asthma development in high risk children. Am J Respir Crit Care Med. 2008;178:667-672.
Midulla F, Pierangeli A, Cangiano G, et al. Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up. Eur Respir J. 2012;39:396-402.
Midulla F, Nicolai A, Ferrara M, et al. Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia. Acta Paediatr (Stockholm). 2014;103:1094-1099.
Nenna R, Fedele G, Frassanito A, et al. Increased T-helper cell 2 response in infants with respiratory syncytial virus bronchiolitis hospitalized outside epidemic peak. Pediatr Infect Dis J. 2020;39(1):61-67.
Farchi S, Forastiere F, Vecchi Brumatti L, et al. Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. BMC Pediatr. 2014;14:36.
Milner AD. Lung volume measurements in childhood. Paediatr Respir Rev. 2000;1(2):135-140.
El Basha NR, Marzouk H, Sherif MM, El, Kholy AA. Prematurity, a significant predictor for worse outcome in viral bronchiolitis: a comparative study in infancy. J. Egyptian Public Healt Assoc. 2019;94(1):15.
Papoff P, Moretti C, Cangiano G, et al. Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis. Acta Pediatr. 2011;100(7):17-23.
Haataja P, Korhonen P, Ojala R, et al. Hospital admissions for lower respiratory tract infections in children born moderately/late preterm. Pediatr Pulmonol. 2018;53(2):209-217.
Resch B, Wörner C, Özdemir S, Hubner M, Puchas C, Urlesberger B. Respiratory syncytial virus associated hospitalizations in infants of 33 to 42 weeks' gestation: does gestational age matter? Klin Padiatr. 2019;231(4):206-211.
Miller JE, Hammond GC, Strunk T, et al. Association of gestational age and growth measures at birth with infection-related admissions to hospital throughout childhood: a population-based, data-linkage study from Western Australia. Lancet Infect Dis. 2016;16(8):952-961.
Lanari M, Prinelli F, Adorni F, et al. Italian Neonatology Study Group on RSV Infections. Maternal milk protects infants against bronchiolitis during the first year of life. Results from an Italian cohort of newborns. Early Hum Dev. 2013;89:S51-S57.
Gdalevich M. Association between breastfeeding and asthma. BMJ. 2015;55(4):209-210.
Hanson LA. Session 1: feeding and infant development breast-feeding and immune function. Proc Nutr Soc. 2007;66(3):384-396.
den Dekker HT, Sonnenschein-van der Voort AMM, Jaddoe VWV, Reiss IK, de Jongste JC, Duijts L.  Breastfeeding and asthma outcomes at the age of 6 years: the Generation R Study. Pediatr Allergy Immunol. 2016;27(5):486-492.
Behrooz L, Balekian DS, Faridi MK, Espinola JA, Townley LP, Camargo CA Jr. Prenatal and postnatal tobacco smoke exposure and risk of severe bronchiolitis during infancy. Resp Med. 2018;140:21-26.
Nicolai A, Frassanito A, Nenna R, et al. Risk factors for virus-induced acute respiratory tract infections in children younger than 3 years and recurrent wheezing at 36 months follow-up after discharge. Pediatr Infect Dis J. 2017;36(2):179-183.
Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics. 2008;122:1196-1203.
Moshammer H, Hoek G, Luttmann-Gibson H, et al. Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med. 2006;173(11):1255-1263.
Waseem M, Akobo SI, Shaikh F, DelaCruz A, Henriquez W, Leber M. Factors predicting asthma in children with acute bronchiolitis. Pediatr Emerg Care. 2019;35:265-267.
Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541-545.
Miller K, Williams JV, Gebretsadik T. Host and viral factors associated with severity of human rhinovirus-associated infant respiratory tract illness. J Allergy Clin Immunol. 2011;127(4):883-891.
Zomer-Kooijker K, van der Ent CK, Ermers MJ, et al. Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection. PLoS ONE. 2014;9(1):e87162.
Turner SW, Palmer LJ, Rye PJ, et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med. 2004;169:921-927.
Samet JM, Tager IB, Speizer FE. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am Rev Respir Dis. 1983 Apr;127(4):508-523.
Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161:1501-1507.

Auteurs

Antonella Frassanito (A)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Raffaella Nenna (R)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Serena Arima (S)

Department of History, Society and Human Studies Statistics for Experimental and Technological Research, University of Salento, Lecce, Italy.

Laura Petrarca (L)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Alessandra Pierangeli (A)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Carolina Scagnolari (C)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Greta Di Mattia (G)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Enrica Mancino (E)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Luigi Matera (L)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Daniela Porta (D)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Franca Rusconi (F)

Unit of Epidemiology, Anna Meyer Children's University Hospital, Florence, Italy.

Fabio Midulla (F)

Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH